Drug Database
Back to search

Netherlands· NL-c08d7b3a9706

Nexavar 200 mg, filmomhulde tabletten

A sorafenib product containing sorafenibtosylaat, registered in Netherlands by Bayer AG. The same ATC class is registered in 14 of our 19 countries.

ATC L01EX02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedNexavar 200 mg, filmomhulde tablettenATCL01EX02REGISTER NO.NL-c08d7b3a9706PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about sorafenibtosylaatAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Sorafenib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EX02 (sorafenib), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search sorafenib products by name

Sorafenib · ATC L01EX02

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of sorafenib costs, country by country.

Normalised to the WHO defined daily dose (0.8 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Sorafenib · price per daily dose (0.8 g)

USD · FX 28 Sept 2026

  • CH Switzerland$125.31
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
SORAFENIBTOSYLAAT
Manufacturer
Bayer AG
Country
Netherlands (NL)
ATC code
L01EX02
ATC class
Sorafenib
Defined daily dose
0.8 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/06/342

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

598 interactions on record for sorafenib.

Graded by severity as the source publishes them — 85 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check sorafenib against other medicinesHow interaction checks work

Sorafenib · interactions on record

598 records

  • 85 severe
  • 352 moderate
  • 11 minor
  • 150 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • EdoxabanB01AF03severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Sorafenib in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All sorafenib products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Sorafenib, Sorafenib Bluefish
  • Belgium · Sorafenib Eg, Sorafénib Eg
  • Bulgaria · Сорафениб Зентива, Сорафениб Тева
  • Cyprus · Rexanib
  • Czechia · Sorafenib Pharmagen, Sorafenib Sandoz
  • Germany · Sorafeb, Sorafenib Abz
  • Denmark · Sorafenib "sandoz", Sorafenib Stada
  • Estonia · Sorafenib Sandoz, Sorafenib Teva
  • Spain · Sorafenib Dr. Reddys, Sorafenib Eugia
  • Finland · Sorafenib Sandoz, Sorafenib Stada
  • France · Sorafenib Arrow, Sorafenib Biogaran
  • United Kingdom (Northern Ireland) · Sorafenib Sandoz, Sorafenib Teva
  • Greece · Revamox, Sorafenib Bioars
  • Croatia · Slam 200 Mg Tablete, Sorafenib Alpha-Medical
  • Hungary · Fenesa, Renixola
  • Iceland · Nexavar, Sorafenib
  • Italy · Sorafenib Eg, Sorafenib Medac
  • Liechtenstein · Nexavar, Sorafenib Accord
  • Lithuania · Sorafenib Sandoz, Sorafenib Teva
  • Luxembourg · Sorafenib Eg, Sorafenib Eurogenerics
  • Latvia · Sorafenib Lv System, Sorafenib Sandoz
  • Malta · Revamox, Sorafenib Pharos
  • Norway · Nexavar, Sorafenib Accord
  • Poland · Sorafenib G.L., Sorafenib Sandoz
  • Portugal · Sorafenib, Sorafenib Eugia
  • Romania · Sorafenib Dr. Reddy's, Sorafenib Sandoz
  • Sweden · Sorafenib Bluefish, Sorafenib Sandoz
  • Slovenia · Sorafenib Sandoz, Sorafenib Teva
  • Slovakia · Sorafenib, Sorafenib Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cf82389f-a243-4be0-83a8-2aa6f29ec45a
GET /v1/drugs/cf82389f-a243-4be0-83a8-2aa6f29ec45a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/nexavar-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Sorafenib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp72996",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "SORAFENIBTOSYLAAT"
  ],
  "leaflet_url": null,
  "authorised_at": "2006/07/19",
  "procedure_number": "EMEA/H/C/000690",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/06/342",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about sorafenib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console